China Healthcare Weekly (July.28)- Ascentage Gets "A Big Gift", CR Boya Acquires Green Cross, Weigao

332 Views28 Jul 2024 13:43

We noticed some positive updates about Ascentage as competitors' products encountered challenges. China Resources Boya acquires Green Cross. Weigao's weak share price is related to its business model.

What is covered in the Full Insight:

Ascentage Competitive Landscape
China Resources Boya Acquisition
Weigao's Performance
Industry Viewpoints
Market Review and Risk Disclosure

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 4-minute read)

Discussions

(Paid Plans Only)

Top 5%

Xinyao (Criss) Wang

HK/China Healthcare Analyst (ex-Fosun Pharma)

ChinaHealth CareEquity Bottom-UpThematic (Sector/Industry)

View Full Profile

Price Chart(Sign Up to Access)

Insight Stream